Capricor Therapeutics met with the FDA last week for a type A meeting, during which CEO Linda Marbán aimed to explain to the ...

VantAI will use its machine learning capabilities to identify novel target-effector pairs that Halda can use in designing its ...

The FDA recommends that companies use overall survival as a primary endpoint for clinical trials where feasible. The new ...

In late May, a patient died after receiving Rocket Pharmaceuticals' investigational gene therapy for Danon disease, spurring ...

Regulations aiming to lower the cost of vital medicines will instead end up restricting access and disincentivizing R&D.

A draft copy of an upcoming MAHA report reveals a strategy in lockstep with recent HHS actions such as reviving the Task ...

With its structural changes, CSL expects to generate $500 to $550 million in annualized savings over the next three years.

Media coverage can help biopharma executives connect with, inform and inspire the public. In this column, ...

The CDC no longer recommends COVID-19 vaccines for healthy children and healthy pregnant women, a position that has been opposed by leading medical societies.